These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16355364

  • 1. [Treatment with valproate and hepatic steatosis].
    Ortiz-Sáenz de Santa María R, Santiago-Fernández C, Cano-Del Pozo M, Pérez-Gil O, Soto-Alvarez MI, Barriuso-Pérez E, Moche-Loeri JA.
    Rev Neurol; ; 41(12):766-7. PubMed ID: 16355364
    [No Abstract] [Full Text] [Related]

  • 2. [Acute hepatic steatosis. Description of a clinical case of sodium valproate-induced acute hepatic steatosis].
    Coraggio F, Angiulli B, Carbone M, Catalano A, Costa MR, Gargiulo L, Gentile B, Masetto O, Pomponio N, Scarpato P.
    Clin Ter; 1988 Mar 31; 124(6):451-63. PubMed ID: 2974353
    [No Abstract] [Full Text] [Related]

  • 3. Hepatic functions in epileptics on sodium valproate monotherapy.
    Jha S, Agarwal DK, Shukla S, Nag D, Saxena RC.
    Indian J Physiol Pharmacol; 1995 Jul 31; 39(3):305-6. PubMed ID: 8550134
    [No Abstract] [Full Text] [Related]

  • 4. Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
    Sharma S, Jacobs HS.
    Curr Opin Obstet Gynecol; 1997 Dec 31; 9(6):391-2. PubMed ID: 9425584
    [No Abstract] [Full Text] [Related]

  • 5. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin.
    Hayashi T, Yoshida S, Yoshinaga A, Ohno R, Ishii N, Yamada T.
    Scand J Urol Nephrol; 2005 Dec 31; 39(5):431-2. PubMed ID: 16257847
    [Abstract] [Full Text] [Related]

  • 6. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL, Sanford M.
    Epilepsia; 2005 Apr 31; 46(4):599-600. PubMed ID: 15816962
    [No Abstract] [Full Text] [Related]

  • 7. Sodium valproate in epilepsy treatment.
    Brown EG.
    Practitioner; 1986 Mar 31; 230(1413):204. PubMed ID: 3086857
    [No Abstract] [Full Text] [Related]

  • 8. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT, Burcet J, Ramió L, Ustrell X, Silva Y, Molins A.
    Neurologia; 2003 Mar 31; 18(6):347-50. PubMed ID: 12838456
    [Abstract] [Full Text] [Related]

  • 9. Valproate-associated coagulopathies are frequent and variable in children.
    Attilakos A, Katsarou E, Voudris K, Garoufi A.
    Epilepsia; 2007 Jan 31; 48(1):205-6. PubMed ID: 17241231
    [No Abstract] [Full Text] [Related]

  • 10. Appropriate clinical management of women taking valproate.
    Piontek CM, Wisner KL.
    J Clin Psychiatry; 2000 Mar 31; 61(3):161-3. PubMed ID: 10817097
    [No Abstract] [Full Text] [Related]

  • 11. Precocious puberty in an epileptic child treated with valproate.
    Zaiem A, Aouinti I, Lakhoua G, Kastalli S, Daghfous R, Lakhal M, El Aïdli S.
    Therapie; 2012 Mar 31; 67(6):537-8. PubMed ID: 23249581
    [No Abstract] [Full Text] [Related]

  • 12. Divalproex and epilepsy.
    Willmore LJ.
    Psychopharmacol Bull; 2003 Mar 31; 37 Suppl 2():43-53. PubMed ID: 15021860
    [Abstract] [Full Text] [Related]

  • 13. [The dangers of valproate in women].
    Isojärvi J.
    Duodecim; 1998 Mar 31; 114(9):825, 827. PubMed ID: 11524801
    [No Abstract] [Full Text] [Related]

  • 14. [Is treatment with a daily dose of Depakine Crono safe?].
    Martínez-Salio A, Porta-Etessam J, Berbel A, Manzanares-Secades C, Alvarez-Tejerina J, De La Peña P.
    Rev Neurol; 1998 Mar 31; 34(11):1095-6. PubMed ID: 12134312
    [No Abstract] [Full Text] [Related]

  • 15. Epilepsy.
    Langendorf F.
    N Engl J Med; 2001 Aug 09; 345(6):468; author reply 468-9. PubMed ID: 11496868
    [No Abstract] [Full Text] [Related]

  • 16. Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy.
    Scott DA, Gholson CF, Netchvolodoff CV, Ray M, Gonzalez E, Bacon BR.
    Am J Gastroenterol; 1991 Apr 09; 86(4):500-2. PubMed ID: 1901443
    [Abstract] [Full Text] [Related]

  • 17. Weight gain in children treated with valproate.
    Sharpe C, Wolfson T, Trauner DA.
    J Child Neurol; 2009 Mar 09; 24(3):338-41. PubMed ID: 19258293
    [Abstract] [Full Text] [Related]

  • 18. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
    Nicolai J, Aldenkamp AP, Huizenga JR, Teune LK, Brouwer OF.
    J Clin Psychopharmacol; 2007 Apr 09; 27(2):221-4. PubMed ID: 17414255
    [No Abstract] [Full Text] [Related]

  • 19. Valproate therapy and nonalcoholic fatty liver disease.
    Luef GJ, Waldmann M, Sturm W, Naser A, Trinka E, Unterberger I, Bauer G, Lechleitner M.
    Ann Neurol; 2004 May 09; 55(5):729-32. PubMed ID: 15122714
    [Abstract] [Full Text] [Related]

  • 20. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE.
    Epilepsy Behav; 2007 Jun 09; 10(4):583-7. PubMed ID: 17412645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.